Inferior Vena Cava (IVC) Filter Market Research Report 2023-2028

Report DescriptionAbout IMARC Group

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Global Inferior Vena Cava (IVC) Filter Market Research Report:

According to the latest report by IMARC Group, titled “

Inferior Vena Cava (IVC) Filter Market: Global Industry Trends, Share, Size, Growth, Opportunity and F orecast 2023-2028

” the global inferior vena cava (IVC) filter market reached a strong growth in 2022.

Inferior vena cava (IVC) is the most prominent vein in the body that is responsible for carrying deoxygenated blood to the heart’s right atrium and then to the lungs. An IVC filter refers to a small piece of device that is implanted into the IVC to prevent blood clots in the legs from traveling to the lungs, thus providing enhanced thromboembolic protection. IVC filters help reduce the risks of pulmonary embolism by trapping large clots while preventing them from reaching the lungs and heart. There are six limbs of stainless steel that radiate from the apex of this cone-shaped filter, which can be inserted either permanently or temporarily. IVC filters are primarily constructed from phynox, an MRIcompatible nonferromagnetic alloy, which contains cobalt, chromium, and nickel. Clinical trials have shown IVC filters are an effective alternative to anticoagulants for preventing mortality due to pulmonary embolism.

Request Free Sample Report:

https://www.imarcgroup.com/inferior-vena-cava-filter-market/requestsample

Global Inferior Vena Cava (IVC) Filter Market Trends :

The rapid usage of IVC filters among patients with acute venous thromboembolic events and failed anticoagulation therapy is one of the key factors driving the growth of the market. This can be attributed to the augmenting prevalence of cardiovascular disorders across the globe. In line with this, a considerable rise in the preference for minimally invasive (MI) surgeries is acting as a significant growth-inducing factor for the market. Continual technological advancements in medical imaging procedures, along with the advent of optional and retrievable IVC filters, are propelling the market. Besides this, the growing numbers of digital catheterization laboratories, along with improvements in the healthcare infrastructure, are creating lucrative growth opportunities in the market. Apart from this, favorable initiatives undertaken by government bodies of several countries for spreading awareness regarding cardiovascular disorders (CVDs) are creating a positive market outlook. Furthermore, an enhanced focus on strategic partnerships, such as acquisitions and mergers by the major market players to augment their global presence, is impacting the market positively. Additionally, the expanding geriatric population that is susceptible to developing a wide range of chronic ailments is also acting as a significant growth-inducing factor for the market. Some of the other factors contributing to the market include rapid urbanization, unhealthy lifestyles led by the masses, increasing healthcare expenditure, and extensive research and development (R&D) activities.

Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).

Report Description Report Description and Highlights

Market Summary:

Product Insights

• Retrievable IVC Filter

• Permanent IVC Filter

Material Insights

• Non-Ferromagnetic Materials

• Ferromagnetic Materials

Application Insights

• Treatment Venous Thromboembolism (VTE)

• Prevent Pulmonary Embolism (PE)

• Others

End User Insights

• Hospitals

• Ambulatory Surgical Centers (ASCs)

• Others

Report Description Report Description and Highlights

Regional Insights:

• North America

• United States

• Canada

• Asia Pacific

• China

• Japan

• India

• South Korea

• Australia

• Indonesia

• Others

• Europe

• Germany

• France

• United Kingdom

• Italy

• Spain

• Russia

• Others

Report Description Report Description and Highlights

• Latin America

• Brazil

• Mexico

• Others

• Middle East and Africa

Note: We are updating our reports, If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report.

Report Description Report Description and Highlights

Competitive Landscape with Key Players: Argon Medical Devices Inc.

B. Braun Melsungen AG

Becton Dickinson and Company

Braile Biomédica

Cook Group Incorporated

Kindly note that this only represents a partial list of companies

• the complete list has been provided in the report

View Full Report with TOC & List of Figure:

https://www.imarcgroup.com/inferior-vena-cava-filter-market

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

Report Description Report Description and Highlights

© 2019 IMARC All Rights Reserved

This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.